ACCL Acco Group Holdings Limited - Fundamental Analysis
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- Graham Number of $0.53 provides a defensive floor
- Intrinsic value estimate of $0.49 supports long-term fair value
- Current price of $1.41 is 2.65x Graham Number
- Price/Book of 8.06 is extremely high for a company with stagnant growth
- No PEG or forward P/E to justify premium valuation
Ref Growth rates
- High ROE and ROIC suggest potential for future profitability
- Low debt levels provide flexibility for reinvestment
- Earnings growth is -24.1% YoY and revenue growth is only 0.70%
- No forward guidance or analyst estimates to support growth expectations
- Q/Q earnings and revenue growth are unavailable, indicating data gaps
Ref Historical trends
- Piotroski F-Score of 7/9 reflects consistent past performance
- Strong historical margins and ROE suggest past operational excellence
- Stock has declined 65.2% over 5 years, 3 years, and 1 year
- No positive price momentum despite strong fundamentals
- Lack of price recovery despite healthy balance sheet
Ref Altman Z-Score, Piotroski F-Score
- Piotroski F-Score of 7/9 indicates strong financial health
- Low debt/equity (0.13) and high current/quick ratios (1.82) show liquidity strength
- No Altman Z-Score provided, creating a critical blind spot in distress risk assessment
- Absence of EV/EBITDA, FCF, and cash flow data limits full health evaluation
Ref Yield, Payout
- No dividend yield, rate, or payout ratio available
- Payout ratio is 0.00%, indicating no dividend distribution
- Dividend strength is 0/100, confirming absence of income feature
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for ACCL and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
ACCL
Acco Group Holdings Limited
Primary
|
-65.2% | -65.2% | -65.2% | -65.2% | -53.0% | -6.0% |
|
AERT
Aeries Technology, Inc
Peer
|
-95.0% | -95.3% | -9.2% | -51.7% | -8.9% | +12.3% |
|
ARTW
Art's-Way Manufacturing Co., Inc.
Peer
|
-17.0% | -6.2% | +31.9% | -19.7% | +6.1% | +2.5% |
|
AIHS
Senmiao Technology Limited
Peer
|
-99.3% | -88.4% | -86.9% | -46.0% | +4.5% | 0.0% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Industrials Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
ACCL
Acco Group Holdings Limited
|
BEARISH | $19.67M | 20.14 | 61.3% | 20.9% | $1.41 | |
|
AERT
Aeries Technology, Inc
|
BEARISH | $24.25M | - | -% | -4.2% | $0.48 | |
|
ARTW
Art's-Way Manufacturing Co., Inc.
|
BEARISH | $12.46M | 6.42 | 16.0% | 10.4% | $2.44 | |
|
BKYI
BIO-key International, Inc.
|
BEARISH | $7.19M | - | -137.7% | -67.3% | $0.66 | |
|
AIHS
Senmiao Technology Limited
|
BEARISH | $5.29M | - | -225.5% | -88.6% | $1.16 |
Past News Coverage
Recent headlines mentioning ACCL from our newsroom.